These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32967650)

  • 1. Systemic TNFα correlates with residual β-cell function in children and adolescents newly diagnosed with type 1 diabetes.
    Overgaard AJ; Madsen JOB; Pociot F; Johannesen J; Størling J
    BMC Pediatr; 2020 Sep; 20(1):446. PubMed ID: 32967650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An improved clinical model to predict stimulated C-peptide in children with recent-onset type 1 diabetes.
    Buchanan K; Mehdi AM; Hughes I; Cotterill A; Le Cao KA; Thomas R; Harris M
    Pediatr Diabetes; 2019 Mar; 20(2):166-171. PubMed ID: 30556344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fasting and meal-stimulated residual beta cell function is positively associated with serum concentrations of proinflammatory cytokines and negatively associated with anti-inflammatory and regulatory cytokines in patients with longer term type 1 diabetes.
    Pham MN; Kolb H; Battelino T; Ludvigsson J; Pozzilli P; Zivehe F; Roden M; Mandrup-Poulsen T; Schloot NC;
    Diabetologia; 2013 Jun; 56(6):1356-63. PubMed ID: 23494449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis for residual islet β-cell secretion function in young patients with newly diagnosed type 1 diabetes.
    Miao H; Zhang J; Gu B; Gao A; Hong J; Zhang Y; Gu W
    J Diabetes; 2019 Oct; 11(10):818-825. PubMed ID: 30848017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune cell and cytokine patterns in children with type 1 diabetes mellitus undergoing a remission phase: A longitudinal study.
    Fitas AL; Martins C; Borrego LM; Lopes L; Jörns A; Lenzen S; Limbert C
    Pediatr Diabetes; 2018 Aug; 19(5):963-971. PubMed ID: 29527790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proinsulin to C-Peptide Ratio in the First Year After Diagnosis of Type 1 Diabetes.
    Freese J; Al-Rawi R; Choat H; Martin A; Lunsford A; Tse H; Mick G; McCormick K
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4318-e4326. PubMed ID: 34228132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in insulin sensitivity in the partial remission phase of childhood type 1 diabetes; a longitudinal cohort study.
    Mørk FCB; Madsen JOB; Jensen AK; Hall GV; Pilgaard KA; Pociot F; Johannesen J
    Diabet Med; 2022 Feb; 39(2):e14702. PubMed ID: 34564895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High T-helper-1 cytokines but low T-helper-3 cytokines, inflammatory cytokines and chemokines in children with high risk of developing type 1 diabetes.
    Stechova K; Bohmova K; Vrabelova Z; Sepa A; Stadlerova G; Zacharovova K; Faresjö M
    Diabetes Metab Res Rev; 2007 Sep; 23(6):462-71. PubMed ID: 17315139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial remission definition: validation based on the insulin dose-adjusted HbA1c (IDAA1C) in 129 Danish children with new-onset type 1 diabetes.
    Max Andersen ML; Hougaard P; Pörksen S; Nielsen LB; Fredheim S; Svensson J; Thomsen J; Vikre-Jørgensen J; Hertel T; Petersen JS; Hansen L; Mortensen HB
    Pediatr Diabetes; 2014 Nov; 15(7):469-76. PubMed ID: 25287319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating microRNA levels predict residual beta cell function and glycaemic control in children with type 1 diabetes mellitus.
    Samandari N; Mirza AH; Nielsen LB; Kaur S; Hougaard P; Fredheim S; Mortensen HB; Pociot F
    Diabetologia; 2017 Feb; 60(2):354-363. PubMed ID: 27866223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Risk Score Modelling for Disease Progression in New-Onset Type 1 Diabetes Patients: Increased Genetic Load of Islet-Expressed and Cytokine-Regulated Candidate Genes Predicts Poorer Glycemic Control.
    Brorsson CA; Nielsen LB; Andersen ML; Kaur S; Bergholdt R; Hansen L; Mortensen HB; Pociot F; Størling J;
    J Diabetes Res; 2016; 2016():9570424. PubMed ID: 26904692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-phasic pattern of C-peptide decline in type 1 diabetes patients with partial remission.
    Shi M; Xie Y; Tang R; Zhong T; Zhou Z; Li X
    Diabetes Metab Res Rev; 2021 Nov; 37(8):e3461. PubMed ID: 33928751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual beta cell function at diagnosis of type 1 diabetes in children and adolescents varies with gender and season.
    Samuelsson U; Lindblad B; Carlsson A; Forsander G; Ivarsson S; Kockum I; Lernmark Å; Marcus C; Ludvigsson J;
    Diabetes Metab Res Rev; 2013 Jan; 29(1):85-9. PubMed ID: 23081842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamic Acid Decarboxylase Injection Into Lymph Nodes: Beta Cell Function and Immune Responses in Recent Onset Type 1 Diabetes Patients.
    Casas R; Dietrich F; Barcenilla H; Tavira B; Wahlberg J; Achenbach P; Ludvigsson J
    Front Immunol; 2020; 11():564921. PubMed ID: 33162978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial.
    de Groot P; Nikolic T; Pellegrini S; Sordi V; Imangaliyev S; Rampanelli E; Hanssen N; Attaye I; Bakker G; Duinkerken G; Joosten A; Prodan A; Levin E; Levels H; Potter van Loon B; van Bon A; Brouwer C; van Dam S; Simsek S; van Raalte D; Stam F; Gerdes V; Hoogma R; Diekman M; Gerding M; Rustemeijer C; de Bakker B; Hoekstra J; Zwinderman A; Bergman J; Holleman F; Piemonti L; De Vos W; Roep B; Nieuwdorp M
    Gut; 2021 Jan; 70(1):92-105. PubMed ID: 33106354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of IL-1ra and adiponectin with C-peptide and remission in patients with type 1 diabetes.
    Pfleger C; Mortensen HB; Hansen L; Herder C; Roep BO; Hoey H; Aanstoot HJ; Kocova M; Schloot NC;
    Diabetes; 2008 Apr; 57(4):929-37. PubMed ID: 18299313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of T-cell reactivity with beta-cell function in recent onset type 1 diabetes patients.
    Pfleger C; Meierhoff G; Kolb H; Schloot NC;
    J Autoimmun; 2010 Mar; 34(2):127-35. PubMed ID: 19744828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Residual β-cell Function in Chinese Patients With Autoimmune Type 1 Diabetes.
    Wang Y; Qin Y; Gu H; Zhang L; Wang J; Huang Y; Shi Y; Hu Q; Chen Y; Gu Y; Shi Y; Tao Y; Zhang M
    J Clin Endocrinol Metab; 2022 May; 107(6):e2348-e2358. PubMed ID: 35218654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General immune dampening is associated with disturbed metabolism at diagnosis of type 1 diabetes.
    Rydén A; Ludvigsson J; Fredrikson M; Faresjö M
    Pediatr Res; 2014 Jan; 75(1-1):45-50. PubMed ID: 24105410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.